Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Wyszukujesz frazę ""Havrilesky LJ"" wg kryterium: Autor


Wyświetlanie 1-17 z 17
Tytuł:
Improving Risk Assessment for Metastatic Disease in Endometrioid Endometrial Cancer Patients Using Molecular and Clinical Features: An NRG Oncology/Gynecologic Oncology Group Study.
Autorzy:
Casablanca Y; Gynecologic Cancer Center of Excellence, Department of Gynecologic Surgery and Obstetrics, Uniformed Services University of the Health Sciences, Walter Reed National Military Medical Center, Bethesda, MD 20889, USA.
Wang G; Gynecologic Cancer Center of Excellence, Department of Gynecologic Surgery and Obstetrics, Uniformed Services University of the Health Sciences, Walter Reed National Military Medical Center, Bethesda, MD 20889, USA.; The Henry M Jackson Foundation for the Advancement of Military Medicine, Inc., Bethesda, MD 20817, USA.
Lankes HA; Gynecologic Oncology Group Statistical and Data Management Center, Roswell Park Comprehensive Cancer Center, Buffalo, NY 14263, USA.
Tian C; Gynecologic Cancer Center of Excellence, Department of Gynecologic Surgery and Obstetrics, Uniformed Services University of the Health Sciences, Walter Reed National Military Medical Center, Bethesda, MD 20889, USA.; The Henry M Jackson Foundation for the Advancement of Military Medicine, Inc., Bethesda, MD 20817, USA.
Bateman NW; Gynecologic Cancer Center of Excellence, Department of Gynecologic Surgery and Obstetrics, Uniformed Services University of the Health Sciences, Walter Reed National Military Medical Center, Bethesda, MD 20889, USA.; The Henry M Jackson Foundation for the Advancement of Military Medicine, Inc., Bethesda, MD 20817, USA.
Miller CR; Gynecologic Cancer Center of Excellence, Department of Gynecologic Surgery and Obstetrics, Uniformed Services University of the Health Sciences, Walter Reed National Military Medical Center, Bethesda, MD 20889, USA.
Chappell NP; Gynecologic Cancer Center of Excellence, Department of Gynecologic Surgery and Obstetrics, Uniformed Services University of the Health Sciences, Walter Reed National Military Medical Center, Bethesda, MD 20889, USA.
Havrilesky LJ; Division of Gynecologic Oncology, Duke University, Durham, NC 27710, USA.
Wallace AH; Division of Gynecologic Oncology, Duke University, Durham, NC 27710, USA.
Ramirez NC; Gynecologic Oncology Group Tissue Bank, Nationwide Children's Hospital, Columbus, OH 43205, USA.
Miller DS; Division of Gynecologic Oncology, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA.
Oliver J; Gynecologic Cancer Center of Excellence, Department of Gynecologic Surgery and Obstetrics, Uniformed Services University of the Health Sciences, Walter Reed National Military Medical Center, Bethesda, MD 20889, USA.; The Henry M Jackson Foundation for the Advancement of Military Medicine, Inc., Bethesda, MD 20817, USA.
Mitchell D; Gynecologic Cancer Center of Excellence, Department of Gynecologic Surgery and Obstetrics, Uniformed Services University of the Health Sciences, Walter Reed National Military Medical Center, Bethesda, MD 20889, USA.; The Henry M Jackson Foundation for the Advancement of Military Medicine, Inc., Bethesda, MD 20817, USA.
Litzi T; Gynecologic Cancer Center of Excellence, Department of Gynecologic Surgery and Obstetrics, Uniformed Services University of the Health Sciences, Walter Reed National Military Medical Center, Bethesda, MD 20889, USA.; The Henry M Jackson Foundation for the Advancement of Military Medicine, Inc., Bethesda, MD 20817, USA.
Blanton BE; Gynecologic Cancer Center of Excellence, Department of Gynecologic Surgery and Obstetrics, Uniformed Services University of the Health Sciences, Walter Reed National Military Medical Center, Bethesda, MD 20889, USA.; The Henry M Jackson Foundation for the Advancement of Military Medicine, Inc., Bethesda, MD 20817, USA.
Lowery WJ; Gynecologic Cancer Center of Excellence, Department of Gynecologic Surgery and Obstetrics, Uniformed Services University of the Health Sciences, Walter Reed National Military Medical Center, Bethesda, MD 20889, USA.
Risinger JI; Department of Obstetrics, Gynecology and Reproductive Biology, Michigan State University, 333 Bostwick Ave., NE, Grand Rapids, MI 49503, USA.
Hamilton CA; Gynecologic Cancer Center of Excellence, Department of Gynecologic Surgery and Obstetrics, Uniformed Services University of the Health Sciences, Walter Reed National Military Medical Center, Bethesda, MD 20889, USA.; Women's Health Integrated Research Center, Women's Service Line, Inova Health System, Falls Church, VA 22042, USA.
Phippen NT; Gynecologic Cancer Center of Excellence, Department of Gynecologic Surgery and Obstetrics, Uniformed Services University of the Health Sciences, Walter Reed National Military Medical Center, Bethesda, MD 20889, USA.; Women's Health Integrated Research Center, Women's Service Line, Inova Health System, Falls Church, VA 22042, USA.
Conrads TP; Gynecologic Cancer Center of Excellence, Department of Gynecologic Surgery and Obstetrics, Uniformed Services University of the Health Sciences, Walter Reed National Military Medical Center, Bethesda, MD 20889, USA.; Women's Health Integrated Research Center, Women's Service Line, Inova Health System, Falls Church, VA 22042, USA.
Mutch D; Division of Gynecologic Oncology, Washington University, St. Louis, MO 63110, USA.
Moxley K; Department of OB/GYN, Section of Gyn Oncology, University of Oklahoma University Health Sciences Center, Oklahoma City, OK 73104, USA.
Lee RB; Department of GYN/ONC, Tacoma General Hospital, Tacoma, WA 98405, USA.
Backes F; Division of Gynecologic Oncology, Ohio State University Comprehensive Cancer Center, Columbus, OH 43210, USA.
Birrer MJ; P. Rockefeller Cancer Institute, Women's Gynecologic Cancer Clinic, Little Rock, AR 72205, USA.
Darcy KM; Gynecologic Cancer Center of Excellence, Department of Gynecologic Surgery and Obstetrics, Uniformed Services University of the Health Sciences, Walter Reed National Military Medical Center, Bethesda, MD 20889, USA.; The Henry M Jackson Foundation for the Advancement of Military Medicine, Inc., Bethesda, MD 20817, USA.
Maxwell GL; Gynecologic Cancer Center of Excellence, Department of Gynecologic Surgery and Obstetrics, Uniformed Services University of the Health Sciences, Walter Reed National Military Medical Center, Bethesda, MD 20889, USA.; Women's Health Integrated Research Center, Women's Service Line, Inova Health System, Falls Church, VA 22042, USA.
Pokaż więcej
Źródło:
Cancers [Cancers (Basel)] 2022 Aug 23; Vol. 14 (17). Date of Electronic Publication: 2022 Aug 23.
Typ publikacji:
Journal Article
Czasopismo naukowe
Tytuł:
Histopathology after lidocaine/prilocaine cream administration for vulvar biopsy.
Autorzy:
Gonzalez R; Division of Gynecologic Oncology, Duke University, Durham, North Carolina, USA.
Dunn A; Department of Pathology, Duke University, Durham, North Carolina, USA.
Williams L; Department of Obstetrics and Gynecology, Duke University, Durham, North Carolina, USA.
Weber J; Department of Biostatistics and Bioinformatics, Duke University, Durham, North Carolina, USA.
Erkanli A; Department of Biostatistics and Bioinformatics, Duke University, Durham, North Carolina, USA.
Havrilesky LJ; Department of Biostatistics and Bioinformatics, Duke University, Durham, North Carolina, USA.
Selim MA; Department of Pathology, Duke University, Durham, North Carolina, USA.
Pokaż więcej
Źródło:
Journal of cutaneous pathology [J Cutan Pathol] 2021 Oct; Vol. 48 (10), pp. 1239-1245. Date of Electronic Publication: 2021 May 02.
Typ publikacji:
Journal Article; Randomized Controlled Trial
MeSH Terms:
Anesthetics, Local/*therapeutic use
Biopsy/*methods
Lidocaine, Prilocaine Drug Combination/*therapeutic use
Vulva/*drug effects
Vulvar Diseases/*diagnosis
Administration, Topical ; Adult ; Aged ; Aged, 80 and over ; Female ; Humans ; Middle Aged
Czasopismo naukowe
Tytuł:
Associations between lymphovascular space invasion, nodal recurrence, and survival in patients with surgical stage I endometrioid endometrial adenocarcinoma.
Autorzy:
Veade AE; Department of Obstetrics and Gynecology, Duke University Medical Center, Box 3084, 200 Trent Drive, Baker House 236, Durham, NC, 27710, USA. .
Foote J; Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Duke University Medical Center, Durham, NC, USA.
Ehrisman J; Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Duke University Medical Center, Durham, NC, USA.
Broadwater G; Department of Biostatistics and Bioinformatics, Duke University Medical Center, Durham, NC, USA.
Davidson BA; Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Duke University Medical Center, Durham, NC, USA.
Lee PS; Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Duke University Medical Center, Durham, NC, USA.
Secord AA; Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Duke University Medical Center, Durham, NC, USA.
Berchuck A; Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Duke University Medical Center, Durham, NC, USA.
Havrilesky LJ; Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Duke University Medical Center, Durham, NC, USA.
Pokaż więcej
Źródło:
World journal of surgical oncology [World J Surg Oncol] 2019 May 10; Vol. 17 (1), pp. 80. Date of Electronic Publication: 2019 May 10.
Typ publikacji:
Journal Article
MeSH Terms:
Adenocarcinoma/*mortality
Carcinoma, Endometrioid/*mortality
Endometrial Neoplasms/*mortality
Lymph Nodes/*pathology
Lymphatic Vessels/*pathology
Neoplasm Recurrence, Local/*mortality
Adenocarcinoma/pathology ; Adenocarcinoma/therapy ; Aged ; Carcinoma, Endometrioid/pathology ; Carcinoma, Endometrioid/therapy ; Combined Modality Therapy ; Endometrial Neoplasms/pathology ; Endometrial Neoplasms/therapy ; Female ; Follow-Up Studies ; Humans ; Middle Aged ; Neoplasm Invasiveness ; Neoplasm Recurrence, Local/pathology ; Neoplasm Recurrence, Local/therapy ; Neoplasm Staging ; Prospective Studies ; Retrospective Studies ; Survival Rate
Czasopismo naukowe
Tytuł:
Sensitivity of ovarian cancer cells to acetaminophen reveals biological pathways that affect patient survival.
Autorzy:
Bush SH; Department of Women's Oncology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL 33612, USA.
Tollin S; Department of Women's Oncology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL 33612, USA.
Marchion DC; Department of Women's Oncology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL 33612, USA.
Xiong Y; Department of Women's Oncology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL 33612, USA.
Abbasi F; Department of Women's Oncology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL 33612, USA.
Ramirez IJ; Department of Women's Oncology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL 33612, USA.
Zgheib NB; Department of Women's Oncology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL 33612, USA.
Boac B; Department of Women's Oncology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL 33612, USA.
Judson PL; Department of Women's Oncology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL 33612, USA.
Chon HS; Department of Women's Oncology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL 33612, USA.
Wenham RM; Department of Women's Oncology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL 33612, USA.
Apte SM; Department of Women's Oncology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL 33612, USA.
Cubitt CL; Translational Research Core, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL 33612, USA.
Berglund AE; Cancer Informatics Core, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL 33612, USA.
Havrilesky LJ; Duke University Medical Center, Durham, NC 27710, USA.
Lancaster JM; Department of Women's Oncology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL 33612, USA.
Pokaż więcej
Źródło:
Molecular and clinical oncology [Mol Clin Oncol] 2016 Mar; Vol. 4 (3), pp. 399-404. Date of Electronic Publication: 2016 Jan 07.
Typ publikacji:
Journal Article
Czasopismo naukowe
Tytuł:
Platinum/taxane-based chemotherapy with or without radiation therapy favorably impacts survival outcomes in stage I uterine papillary serous carcinoma.
Autorzy:
Fader AN (AUTHOR)
Drake RD (AUTHOR)
O'Malley DM (AUTHOR)
Gibbons HE (AUTHOR)
Huh WK (AUTHOR)
Havrilesky LJ (AUTHOR)
Gehrig PA (AUTHOR)
Tuller E (AUTHOR)
Axtell AE (AUTHOR)
Zanotti KM (AUTHOR)
Uterine Papillary Serous Carcinoma (UPSC) Consortium (CORPORATE AUTHOR)
Fader, Amanda Nickles (AUTHOR)
Drake, Richard D (AUTHOR)
O'Malley, David M (AUTHOR)
Gibbons, Heidi E (AUTHOR)
Huh, Warner K (AUTHOR)
Havrilesky, Laura J (AUTHOR)
Gehrig, Paola A (AUTHOR)
Tuller, Erin (AUTHOR)
Axtell, Allison E (AUTHOR)
Pokaż więcej
Źródło:
Cancer (0008543X). 5/15/2009, Vol. 115 Issue 10, p2119-2127. 9p.
Czasopismo naukowe
Tytuł:
Phase I/II trial of intravenous Doxil and whole abdomen hyperthermia in patients with refractory ovarian cancer.
Autorzy:
Alvarez Secord A; Department of Obstetrics and Gynecology, Division of Gynecologic Oncology, West Virginia University Schools of Pharmacy & Medicine, Morgantown, WV 26506, USA. />Jones EL
Hahn CA
Petros WP
Yu D
Havrilesky LJ
Soper JT
Berchuck A
Spasojevic I
Clarke-Pearson DL
Prosnitz LR
Dewhirst MW
Pokaż więcej
Źródło:
International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group [Int J Hyperthermia] 2005 Jun; Vol. 21 (4), pp. 333-47.
Typ publikacji:
Clinical Trial; Clinical Trial, Phase I; Clinical Trial, Phase II; Journal Article; Research Support, N.I.H., Extramural; Research Support, U.S. Gov't, P.H.S.
MeSH Terms:
Hyperthermia, Induced*/adverse effects
Antineoplastic Agents/*therapeutic use
Doxorubicin/*therapeutic use
Ovarian Neoplasms/*therapy
Aged ; Antineoplastic Agents/adverse effects ; Antineoplastic Agents/pharmacokinetics ; Combined Modality Therapy ; Doxorubicin/adverse effects ; Doxorubicin/pharmacokinetics ; Female ; Humans ; Middle Aged ; Ovarian Neoplasms/drug therapy ; Quality of Life
Czasopismo naukowe
    Wyświetlanie 1-17 z 17

    Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies